{"id":16059,"date":"2024-09-05T10:23:00","date_gmt":"2024-09-05T06:23:00","guid":{"rendered":"https:\/\/gbc1.net\/?p=16059"},"modified":"2024-12-10T10:43:08","modified_gmt":"2024-12-10T06:43:08","slug":"eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt","status":"publish","type":"post","link":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/","title":{"rendered":"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt"},"content":{"rendered":"\n<p>On 4 September 2024, US pharma Eli Lilly announced that it has licensed to Eva Pharma to manufacture its drug for rheumatoid arthritis in Egypt. Under the agreement, Eva Pharma will manufacture the drug Olumiant and will hold the distribution rights to 49 countries across Africa.<\/p>\n\n\n\n<p>Olumiant is a medicine used to treat an autoimmune disfunction called alopecia areata which causes rheumatoid arthritis and hair loss. In 2023, Eli Lily registered  $922.6 million in sales of Olumiant.<\/p>\n\n\n\n<p>Since 2021, Lily and Eva have partnered to produce insulin in Egypt. With this new agreement, both parties seek to expand the partnership and replicate the success on the African market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 4 September 2024, US pharma Eli Lilly announced that it has licensed to Eva Pharma to manufacture its drug<\/p>\n","protected":false},"author":1,"featured_media":16066,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_mi_skip_tracking":false,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":0,"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":""},"categories":[10],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.12 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt\" \/>\n<meta property=\"og:description\" content=\"On 4 September 2024, US pharma Eli Lilly announced that it has licensed to Eva Pharma to manufacture its drug\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/\" \/>\n<meta property=\"og:site_name\" content=\"Global Business Council (GBC)\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-05T06:23:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-10T06:43:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gbc1.net\/wp-content\/uploads\/2024\/12\/EVA-01w-jpg.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gbc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"gbc\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/\"},\"author\":{\"name\":\"gbc\",\"@id\":\"https:\/\/gbc1.net\/#\/schema\/person\/cab6d6e84e5294af65e6aa76c5752fad\"},\"headline\":\"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt\",\"datePublished\":\"2024-09-05T06:23:00+00:00\",\"dateModified\":\"2024-12-10T06:43:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/\"},\"wordCount\":114,\"publisher\":{\"@id\":\"https:\/\/gbc1.net\/#organization\"},\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/\",\"url\":\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/\",\"name\":\"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/gbc1.net\/#website\"},\"datePublished\":\"2024-09-05T06:23:00+00:00\",\"dateModified\":\"2024-12-10T06:43:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/gbc1.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gbc1.net\/#website\",\"url\":\"https:\/\/gbc1.net\/\",\"name\":\"Global Business Council (GBC)\",\"description\":\"Connecting ... Dots\",\"publisher\":{\"@id\":\"https:\/\/gbc1.net\/#organization\"},\"alternateName\":\"GBC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gbc1.net\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/gbc1.net\/#organization\",\"name\":\"Global Business Council (GBC)\",\"alternateName\":\"GBC\",\"url\":\"https:\/\/gbc1.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gbc1.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/gbc1.net\/wp-content\/uploads\/2023\/07\/GBC.png\",\"contentUrl\":\"https:\/\/gbc1.net\/wp-content\/uploads\/2023\/07\/GBC.png\",\"width\":1200,\"height\":200,\"caption\":\"Global Business Council (GBC)\"},\"image\":{\"@id\":\"https:\/\/gbc1.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/globiznet\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/gbc1.net\/#\/schema\/person\/cab6d6e84e5294af65e6aa76c5752fad\",\"name\":\"gbc\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gbc1.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d885239a5c83809eb00f912fef7d8048?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d885239a5c83809eb00f912fef7d8048?s=96&d=mm&r=g\",\"caption\":\"gbc\"},\"sameAs\":[\"https:\/\/gbc1.net\"],\"url\":\"https:\/\/gbc1.net\/index.php\/author\/gbc\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/","og_locale":"en_US","og_type":"article","og_title":"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt","og_description":"On 4 September 2024, US pharma Eli Lilly announced that it has licensed to Eva Pharma to manufacture its drug","og_url":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/","og_site_name":"Global Business Council (GBC)","article_published_time":"2024-09-05T06:23:00+00:00","article_modified_time":"2024-12-10T06:43:08+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/gbc1.net\/wp-content\/uploads\/2024\/12\/EVA-01w-jpg.webp","type":"image\/jpeg"}],"author":"gbc","twitter_card":"summary_large_image","twitter_misc":{"Written by":"gbc","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/#article","isPartOf":{"@id":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/"},"author":{"name":"gbc","@id":"https:\/\/gbc1.net\/#\/schema\/person\/cab6d6e84e5294af65e6aa76c5752fad"},"headline":"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt","datePublished":"2024-09-05T06:23:00+00:00","dateModified":"2024-12-10T06:43:08+00:00","mainEntityOfPage":{"@id":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/"},"wordCount":114,"publisher":{"@id":"https:\/\/gbc1.net\/#organization"},"articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/","url":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/","name":"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt","isPartOf":{"@id":"https:\/\/gbc1.net\/#website"},"datePublished":"2024-09-05T06:23:00+00:00","dateModified":"2024-12-10T06:43:08+00:00","breadcrumb":{"@id":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gbc1.net\/index.php\/2024\/09\/05\/eli-lilly-licenses-eva-pharma-to-produce-rheumatoid-arthritis-drug-in-egypt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gbc1.net\/"},{"@type":"ListItem","position":2,"name":"Eli Lilly Licenses Eva Pharma to Produce Rheumatoid Arthritis Drug in Egypt"}]},{"@type":"WebSite","@id":"https:\/\/gbc1.net\/#website","url":"https:\/\/gbc1.net\/","name":"Global Business Council (GBC)","description":"Connecting ... Dots","publisher":{"@id":"https:\/\/gbc1.net\/#organization"},"alternateName":"GBC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gbc1.net\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/gbc1.net\/#organization","name":"Global Business Council (GBC)","alternateName":"GBC","url":"https:\/\/gbc1.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gbc1.net\/#\/schema\/logo\/image\/","url":"https:\/\/gbc1.net\/wp-content\/uploads\/2023\/07\/GBC.png","contentUrl":"https:\/\/gbc1.net\/wp-content\/uploads\/2023\/07\/GBC.png","width":1200,"height":200,"caption":"Global Business Council (GBC)"},"image":{"@id":"https:\/\/gbc1.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/globiznet\/"]},{"@type":"Person","@id":"https:\/\/gbc1.net\/#\/schema\/person\/cab6d6e84e5294af65e6aa76c5752fad","name":"gbc","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gbc1.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d885239a5c83809eb00f912fef7d8048?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d885239a5c83809eb00f912fef7d8048?s=96&d=mm&r=g","caption":"gbc"},"sameAs":["https:\/\/gbc1.net"],"url":"https:\/\/gbc1.net\/index.php\/author\/gbc\/"}]}},"_links":{"self":[{"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/posts\/16059"}],"collection":[{"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/comments?post=16059"}],"version-history":[{"count":5,"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/posts\/16059\/revisions"}],"predecessor-version":[{"id":16068,"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/posts\/16059\/revisions\/16068"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/media\/16066"}],"wp:attachment":[{"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/media?parent=16059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/categories?post=16059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gbc1.net\/index.php\/wp-json\/wp\/v2\/tags?post=16059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}